Device brand name · Surgical mesh
Orthadapt Bioimplant: medical device reports filed with FDA
197 reports name it, 2007–2011. Manufacturer given most often on reports: Pegasus Biologics. Product code FTM.
- 197
- device reports naming the brand
- 0% of all MAUDE reports · about 10 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 0.5%
- classified as malfunction
- 5.2% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
197 medical device reports received by FDA name the brand "Orthadapt Bioimplant" (surgical mesh); the manufacturer given most often on reports is Pegasus Biologics; received from April 2007 to July 2011. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99%) and malfunction (0.5%); across all mesh, surgical reports (product code FTM) death is recorded in 0.4% and malfunction in 5.2%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are insufficient device problem information (72.6%), device slipped (5.1%) and torn material (3%). The patient problems coded most often are swelling, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
No report naming Orthadapt Bioimplant was received in the five years to August 2026; the latest was received in July 2011.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 11,623 reports carrying product code FTM. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Insufficient device problem information | 143 | 72.6% | 36.3% |
| Device slipped | 10 | 5.1% | 0.2% |
| Torn material | 6 | 3% | 0.8% |
| Detachment of device component | 4 | 2% | 0.8% |
| Improper or incorrect procedure or method | 4 | 2% | 0.2% |
| Device dislodged or dislocated | 3 | 1.5% | 0.2% |
| Material protrusion/extrusion | 3 | 1.5% | 0% |
| Failure to adhere or bond | 2 | 1% | 0% |
| Device operates differently than expectedthe device behaved unexpectedly | 1 | 0.5% | 1.7% |
| Folded | 1 | 0.5% | 0% |
| Loose or intermittent connection | 1 | 0.5% | 0% |
| Material frayed | 1 | 0.5% | 0% |
| Material rupture | 1 | 0.5% | 0.1% |
| Material separation | 1 | 0.5% | 0.1% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Swellingswelling | 60 | 30.5% |
| Painpain, site not specified | 47 | 23.9% |
| Inflammationinflammation | 33 | 16.8% |
| Rupturethe device burst | 24 | 12.2% |
| Fluid discharge | 21 | 10.7% |
| Erythemaskin redness | 15 | 7.6% |
| Bacterial infectiona bacterial infection | 13 | 6.6% |
| Wound dehiscencea wound reopened | 13 | 6.6% |
| Abscessa collection of pus | 11 | 5.6% |
| Discharge | 8 | 4.1% |
| Falla fall | 8 | 4.1% |
| Necrosisdeath of tissue | 8 | 4.1% |
| Reactiona reaction, type not specified | 8 | 4.1% |
| Foreign body reaction | 7 | 3.6% |
| Loss of range of motion | 6 | 3% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Orthadapt Bioimplant | Product code FTM | All MAUDE reports |
|---|---|---|---|
| Reports | 197 | 11,623 | 26,136,888 |
| Share of that pool | — | 1.7% | 0% |
| Classified as death, per 1,000 reports | 0 | 4 | 9 |
| Classified as injury | 99% | 87.1% | 36.2% |
| Classified as malfunction | 0.5% | 5.2% | 62.3% |
| Filed by the manufacturer | 99% | 96.2% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code FTM
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Unspecified By Complainant | 2,005 | 0 | 0% |
| Gynecare Mesh Unknown | 5,830 | 3 | 0.1% |
| Pelvisoft Acellular Collagen Biomesh | 1,016 | 0 | 0% |
| Xenform | 781 | 0 | 0% |
| Strattice | 320 | 0 | 1.9% |
| Unknown Strattice | 295 | 47 | 0.7% |
| Mesh Tsl - Permacol | 305 | 4 | 2.6% |
| XenMatrix | 278 | 8 | 0.7% |
| Permacol | 380 | 1 | 0.5% |
| Unk - Unspecified By The Complainant | 272 | 0 | 0% |
| Biodesign 4-Layer Tissue Graft | 204 | 0 | 0% |
| Unknown - Unspecified By The Complainant | 241 | 0 | 0% |
| Veritas Collagen Matrix | 206 | 0 | 0.5% |
| Uphold Vaginal Support System | 1,861 | 0 | 0.1% |
| Unspecified By The Complainant | 545 | 0 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Orthadapt Bioimplant reports
How many FDA reports name Orthadapt Bioimplant?
197 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
injury (99%) and malfunction (0.5%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
insufficient device problem information (72.6%), device slipped (5.1%), torn material (3%), detachment of device component (2%) and improper or incorrect procedure or method (2%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (99%) and voluntary reports (0.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Orthadapt Bioimplant was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.